Jeffrey R. Luber, President & Chief Executive Officer
Mr. Luber has served in numerous senior roles in both public and private companies including Vice President of Finance & Administration and legal counsel for Kaon Interactive Inc. and Assistant Vice President and Associate General Counsel at Concentra Managed Care, Inc., a publicly-traded provider of managed care services. Mr. Luber received his J.D. and M.B.A. from Suffolk University and has been with EXACT Sciences since November 2002.
Charles R. Carelli, Jr., Chief Financial Officer
Mr. Carelli has served as Vice President of Finance, Controller and Principal Accounting Officer since joining the company in 2004. Prior to joining EXACT, Mr. Carelli was Controller and Director of Finance at Alkermes, Inc., and previously, Director of Accounting at Creative BioMolecules, Inc, two publicly-traded pharmaceutical companies. Earlier in his career, Mr. Carelli was employed by Deloitte & Touche LLP. Mr. Carelli is a Certified Public Accountant and holds a BA in Accounting from Assumption College.
Barry M. Berger MD FCAP, Chief Medical Officer
Dr. Berger joined EXACT Sciences in 1999. He received his MD from the University of Pennsylvania. Dr. Berger has had a faculty appointment at Harvard Medical School and has been affiliated staff in Pathology at Brigham and Women's Hospital since 1982. His post graduate training includes a post doctoral fellowship in immunology (University of Pennsylvania), medical internship at Boston University Hospital, and Residency/Chief Resident in Pathology at Brigham and Women's Hospital in Boston, MA. Dr. Berger is boarded in Anatomic, Clinical and Cytologic pathology. Earlier in his career, Dr. Berger spent 11 years as the Director of the Department of Pathology and Laboratory Medicine of Harvard Pilgrim Healthcare. He is the past chairman of the Advisory Committee on Clinical Laboratories for the Commonwealth of MA and currently serves on the Executive Committee of the Massachusetts Society of Pathologists, the Economics Committee of the American College of Medical Genetics, and the Health policy Task Group of the National Colorectal Cancer Roundtable.
back to top